Picture of SCHOTT Pharma AG & Co KgaA logo

1SXP SCHOTT Pharma AG & Co KgaA Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Annual cashflow statement for SCHOTT Pharma AG & Co KgaA, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line77.6101126152
Depreciation
Deferred Taxes
Non-Cash Items3.659.8625-2.1
Unusual Items
Other Non-Cash Items
Changes in Working Capital-9.16-17-27.3-15.7
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities104132182182
Capital Expenditures-85.3-98.6-153-176
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items4.092.7310.64.11
Sale of Fixed Assets
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-81.2-95.9-142-171
Financing Cash Flow Items-14.3-26-40.911
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-14.4-27.5-42.4-11.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.959.250.935-4.44